Meador CB, Hata AN. Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights. Pharmacol Ther. 2020 Jun;210:107522. doi: 10.1016/j.pharmthera.2020.107522. Epub 2020 Mar 6. PMID: 32151666.
Hata Lab
MGH Cancer Center, Room 7.310
149 13th Street, Charlestown, MA 02129 Contact Us